According to CCTV finance reported on July 29, in the past many years, China has largely relied on imports in the field of high-end medical equipment, and now this situation is quietly changing with the success of major technological research.
Recently, the success of a number of major technologies, including fiber spectrometer, dual-energy gradient system, gradient amplifier, etc., marks the realization of 100% independent research and development of core components of domestic 3.0T magnetic resonance equipment.
Liu Jiren, chairman of Neusoft Group, said that the goal now is to install equipment to the most basic level in the future, and the problem is to solve the problem of medical equity and medical accessibility. On December 20 last year, Neusoft Medical's first dual-energy 3.0T magnetic resonance NeuMR Universal was officially released online, marking the company's realization of all core technologies from 1.5T to 3.0T magnetic resonance imaging (MR) system autonomous and controllable.
The reporter called the company United Film Medical (688271.SH) as an investor on localization and product cost reduction, relevant people said that as domestic manufacturers are getting better and better, the industry chain will also achieve domestic. In the current environment, "cost reduction" is a path that everyone will consider.
When it comes to whether falling production costs will lead to lower selling prices, these people said that different products have different prices and configurations. In addition, there are many series of each product, so it is impossible to respond.
It is understood that there are a number of domestic manufacturers involved in the production of magnetic resonance equipment. Chen Guang Medical disclosed in May that the 3.0T magnetic resonance machine is currently in the preparation stage, and the company will start the follow-up system integration and product registration work according to the development progress of 3.0T core components, and the general registration cycle is 2-3 years.
United Film Medical also disclosed in May that the company has the development technology of 1.5T, 3.0T, 5.0T and higher field strength superconducting magnets, and developed the industry's first 75cm large aperture 3.0T, 5.0T whole body magnetic resonance products and the first domestic 3.0TMR, 9.4T animal MR Products.
Wandong Medical disclosed in the 2023 annual report that as of 2023, there are more than 15 domestic magnetic resonance enterprises (including international brands), and the company ranks sixth in the total magnetic resonance ranking, as well as the superconducting 1.5T magnetic resonance market sales, ranking the top three domestic brands, and plans to launch high-end magnetic resonance products.
Mobile website